Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Glycolytic Stimulation Is Not a Requirement for M2 Macrophage Differentiation.

Cell metabolism·2018
Same author

Hypercholesterolemia after conversion to sirolimus as primary immunosuppression and cardiac allograft vasculopathy in heart transplant recipients.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2018
Same author

Ubiquitous yet unseen: microvascular endothelial dysfunction beyond the heart.

European heart journal·2018
Same author

Cardiorenal biomarkers: one step closer.

Journal of laboratory and precision medicine·2018
Same author

Microvascular obstruction in non-infarct related coronary arteries is an independent predictor of major adverse cardiovascular events in patients with ST segment-elevation myocardial infarction.

International journal of cardiology·2018
Same author

Coronary endothelial function and spontaneous coronary artery dissection.

European heart journal. Acute cardiovascular care·2018

相关实验视频

Updated: Jun 23, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

冠状动脉内皮功能障碍与脑血管事件的风险增加有关.

Paul V Targonski1, Piero O Bonetti, Geralyn M Pumper

  • 1Division of Community Internal Medicine, Mayo Clinic and Foundation, Rochester, Minn 55905, USA.

Circulation
|May 29, 2003
PubMed
概括
此摘要是机器生成的。

冠状动脉内皮功能障碍 (CED) 在没有阻塞性冠状动脉疾病的患者中显著增加脑血管事件风险. 早期发现CED有助于识别高风险个体,并采取积极的预防策略.

更多相关视频

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
08:35

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction

Published on: August 17, 2022

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

相关实验视频

Last Updated: Jun 23, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
08:35

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction

Published on: August 17, 2022

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

科学领域:

  • 心脏病学 心脏病学
  • 神经学 神经学
  • 血管生物学 血管生物学

背景情况:

  • 卒中是导致残疾和死亡的主要原因,通常与动脉血性疾病有关.
  • 内皮功能障碍是动脉动脉生成和心血管事件风险的一个关键因素.
  • 冠状动脉内皮功能障碍 (CED) 和脑血管事件之间的关联尚未得到充分证实.

研究的目的:

  • 在没有阻塞性冠状动脉疾病 (CAD) 的患者中调查CED和脑血管事件之间的关联.

主要方法:

  • 503名没有阻塞性CAD的患者通过冠状动脉乙胆输液进行了冠状动脉内皮功能测试.
  • 患者根据CED的存在或不存在来分类.
  • 检查了医疗记录,以查看流行和发生的脑血管事件 (中风,过渡性缺血性发作).

主要成果:

  • 发生了25次脑血管事件;22例是患有CED的患者,而3例是没有CED的患者 (P=0.008).
  • 在调整风险因素后,CED是脑血管事件最强的独立预测因素 (OR,4.32;95% CI,1.26至14.83).
  • 患有CED的患者显示,累计脑血管事件发生率明显高 (P=0.04).

结论:

  • 在没有阻塞性CAD的患者中,冠状动脉内皮功能障碍独立地与脑血管事件的风险增加有关.
  • 检测CED可以识别早期动脉样硬化,并将患者标记为加强预防措施.